{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:07:12Z","timestamp":1778666832868,"version":"3.51.4"},"reference-count":34,"publisher":"The Journal of Rheumatology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To assess whether the 2003 and 2014 French guidelines on the prevention and treatment of glucocorticoid-induced osteoporosis (GIOP) and the 2012 update of the French guidelines for the treatment of postmenopausal osteoporosis (PMOP) were applied in patients with rheumatoid arthritis (RA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We conducted a cross-sectional study of 776 patients with RA (19 centers). We collected the data required for the application of the various recommendations (age, sex, prednisone intake, low-energy fracture, history in the immediate family of hip fractures, and bone densitometry), anti-osteoporotic drugs, and the various factors that may be associated with the application of the recommendations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Of the patients who should have received antiosteoporosis treatment, there were 22.6% actually treated (according to the 2014 guidelines), 27.3% actually treated according to the 2003 guidelines, and of postmenopausal women, 23.6% (according to the 2012 PMOP guidelines). Applying the 2014 GIOP guidelines increased the theoretical number of patients requiring treatment relative to the 2003 GIOP guidelines (77% vs 53%; p &lt; 0.001). In multivariate analysis, being treated was associated with a spinal T score \u2264 \u22122 SD according to the 2014 guidelines; with not taking part in physical activity for more than 30 min a day according to the 2003 guidelines; and with older age, lower body mass index, and a T score \u2264 \u22122.5 SD in at least 1 site according to the PMOP guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Patients with RA had inadequate prevention of GIOP and PMOP. The management of osteoporosis needs to be improved in this population.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.180889","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T18:01:34Z","timestamp":1552672894000},"page":"6-14","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of the Implementation of Guidelines on the Treatment of Osteoporosis in Patients with Rheumatoid Arthritis"],"prefix":"10.3899","volume":"47","author":[{"given":"Sandrine","family":"Malochet-Guinamand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Gossec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Soubrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"key":"2022092307201002000_47.1.6.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10408"},{"key":"2022092307201002000_47.1.6.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1584-3"},{"key":"2022092307201002000_47.1.6.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.22117"},{"key":"2022092307201002000_47.1.6.4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12891-015-0733-9","article-title":"Prevalence of fractures in women with rheumatoid arthritis and\/or systemic lupus erythematosus on chronic glucocorticoid therapy","volume":"16","author":"Rentero","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"2022092307201002000_47.1.6.5","doi-asserted-by":"crossref","first-page":"e6983","DOI":"10.1097\/MD.0000000000006983","article-title":"Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis","volume":"96","author":"Xue","year":"2017","journal-title":"Medicine"},{"key":"2022092307201002000_47.1.6.6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00774-015-0716-9","article-title":"Bone mineral density of postmenopausal women with rheumatoid arthritis depends on disease duration regardless of treatment","volume":"35","author":"Mori","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"2022092307201002000_47.1.6.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0747-2"},{"key":"2022092307201002000_47.1.6.8","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-004-0989-1"},{"key":"2022092307201002000_47.1.6.9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210135"},{"key":"2022092307201002000_47.1.6.10","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181a5679d"},{"key":"2022092307201002000_47.1.6.11","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22519"},{"key":"2022092307201002000_47.1.6.12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204733"},{"key":"2022092307201002000_47.1.6.13","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199908)42:8<1736::AID-ANR24>3.0.CO;2-E"},{"key":"2022092307201002000_47.1.6.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-005-2016-z"},{"key":"2022092307201002000_47.1.6.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0345-9"},{"key":"2022092307201002000_47.1.6.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-013-2562-8"},{"key":"2022092307201002000_47.1.6.17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes079"},{"key":"2022092307201002000_47.1.6.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.22462"},{"key":"2022092307201002000_47.1.6.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.10613"},{"key":"2022092307201002000_47.1.6.20","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000249"},{"key":"2022092307201002000_47.1.6.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2014.10.001"},{"key":"2022092307201002000_47.1.6.22","first-page":"1137","article-title":"[Medicated treatment of cortisone osteoporosis]","volume":"70","year":"2003","journal-title":"Rev Rhum"},{"key":"2022092307201002000_47.1.6.23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbspin.2012.02.014","article-title":"2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis","volume":"79","author":"Briot","year":"2012","journal-title":"Joint Bone Spine"},{"key":"2022092307201002000_47.1.6.24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jbspin.2014.02.001","article-title":"There is still a care gap in osteoporosis management for patients with rheumatoid arthritis","volume":"81","author":"Watt","year":"2014","journal-title":"Joint Bone Spine"},{"key":"2022092307201002000_47.1.6.25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/acr.23331","article-title":"Trends and determinants of osteoporosis treatment and screening in patients with rheumatoid arthritis compared to osteoarthritis","volume":"70","author":"Ozen","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2022092307201002000_47.1.6.26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091368"},{"key":"2022092307201002000_47.1.6.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-014-9856-5"},{"key":"2022092307201002000_47.1.6.28","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-013-0136-1"},{"key":"2022092307201002000_47.1.6.29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11657-017-0317-4","article-title":"Low prevalence of osteoporosis treatment in patients with recurrent major osteoporotic fracture","volume":"12","author":"Flais","year":"2017","journal-title":"Arch Osteoporos"},{"key":"2022092307201002000_47.1.6.30","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00198-015-3098-x","article-title":"Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000\u20132010","volume":"26","author":"Klop","year":"2015","journal-title":"Osteoporos Int"},{"key":"2022092307201002000_47.1.6.31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2015.01.014","article-title":"Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study","volume":"128","author":"Kim","year":"2015","journal-title":"Am J Med"},{"key":"2022092307201002000_47.1.6.32","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200108"},{"key":"2022092307201002000_47.1.6.33","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.injury.2016.07.034","article-title":"Factors associated with receiving anti-osteoporosis treatment among older persons with minimal trauma hip fracture presenting to an acute orthogeriatric service","volume":"47","author":"Gunathilake","year":"2016","journal-title":"Injury"},{"key":"2022092307201002000_47.1.6.34","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00198-009-0837-x","article-title":"Osteoporosis management among residents living in long-term care","volume":"20","author":"Giangregorio","year":"2009","journal-title":"Osteoporos Int"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.180889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T14:23:41Z","timestamp":1663943021000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.180889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,1]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.3899\/jrheum.180889"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.180889","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]}}}